ACAD
40.82
+0.72
+1.80%
AEMD
8.63
-0.02
-0.23%
APRI
1.62
+0.03
+1.89%
ARNA
4.01
-0.09
-2.20%
ATEC
1.36
+0.01
+0.74%
CNAT
5.35
+0.18
+3.48%
CRXM
0.466
-0.024
-4.880%
CYTX
0.689
+0.021
+3.1582%
DXCM
71.64
+2.99
+4.36%
GNMK
9.26
+0.21
+2.32%
HALO
17.82
+0.08
+0.45%
ILMN
209.47
+4.38
+2.14%
INNV
0.15
0.00
+2.39%
INO
8.39
+0.03
+0.36%
ISCO
0.05
0.00
+4.17%
ISIS
67.72
+0.73
+1.09%
LGND
87.26
-1.91
-2.14%
LPTN
0.3
+0.002
+0.6709%
MBVX
2.34
+0.14
+6.36%
MEIP
1.91
+0.1
+5.52%
MNOV
3.95
-0.05
-1.25%
MRTX
33.75
+5.41
+19.09%
MSTX
0.511
+0.018
+3.5678%
NBIX
42.94
+0.64
+1.51%
NUVA
48.78
+0.3
+0.62%
ONCS
0.233
0.00
0.00%
ONVO
4.79
+0.12
+2.57%
OREX
4.93
-0.02
-0.30%
OTIC
24.46
0.00
0.00%
QDEL
22.41
+0.3
+1.36%
RCPT
165.65
+0.83
+0.50%
RGLS
13.63
+0.73
+5.66%
RMD
58.1
+0.68
+1.18%
SCIE
0.018
+0.002
+12.1795%
SPHS
1.08
+0.2
+22.03%
SRNE
13.04
+0.13
+1.01%
TROV
11.19
+0.23
+2.10%
VICL
0.922
+0.002
+0.2609%
VOLC
17.99
0.00
0.00%
ZGNX
1.47
+0.08
+5.76%
ACAD
40.82
+0.72
+1.80%
AEMD
8.63
-0.02
-0.23%
APRI
1.62
+0.03
+1.89%
ARNA
4.01
-0.09
-2.20%
ATEC
1.36
+0.01
+0.74%
CNAT
5.35
+0.18
+3.48%
CRXM
0.466
-0.024
-4.880%
CYTX
0.689
+0.021
+3.1582%
DXCM
71.64
+2.99
+4.36%
GNMK
9.26
+0.21
+2.32%
HALO
17.82
+0.08
+0.45%
ILMN
209.47
+4.38
+2.14%
INNV
0.15
0.00
+2.39%
INO
8.39
+0.03
+0.36%
ISCO
0.05
0.00
+4.17%
ISIS
67.72
+0.73
+1.09%
LGND
87.26
-1.91
-2.14%
LPTN
0.3
+0.002
+0.6709%
MBVX
2.34
+0.14
+6.36%
MEIP
1.91
+0.1
+5.52%
MNOV
3.95
-0.05
-1.25%
MRTX
33.75
+5.41
+19.09%
MSTX
0.511
+0.018
+3.5678%
NBIX
42.94
+0.64
+1.51%
NUVA
48.78
+0.3
+0.62%
ONCS
0.233
0.00
0.00%
ONVO
4.79
+0.12
+2.57%
OREX
4.93
-0.02
-0.30%
OTIC
24.46
0.00
0.00%
QDEL
22.41
+0.3
+1.36%
RCPT
165.65
+0.83
+0.50%
RGLS
13.63
+0.73
+5.66%
RMD
58.1
+0.68
+1.18%
SCIE
0.018
+0.002
+12.1795%
SPHS
1.08
+0.2
+22.03%
SRNE
13.04
+0.13
+1.01%
TROV
11.19
+0.23
+2.10%
VICL
0.922
+0.002
+0.2609%
VOLC
17.99
0.00
0.00%
ZGNX
1.47
+0.08
+5.76%
Home » Archive by Category

Xconomy

From Iceland to White House, Precision Medicine’s Promises & Hurdles

March 31, 2015 – 3:30 am

[Updated and corrected, 4/5/15, 6:51 pm. See below.] There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week,…

[[Click headline to continue reading.]]

Teva Agrees to Buy San Diego’s Auspex Pharmaceuticals for $3B+

March 30, 2015 – 9:09 am

Israel’s Teva Pharmaceutical Industries (NYSE: TEVA) says today it has agreed to acquire San Diego-based Auspex Pharmaceuticals (NASDAQ: ASPX) in a cash deal valued between $3.2 billion and $3.5…

[[Click headline to continue reading.]]

In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital

March 17, 2015 – 3:30 am

[Corrected 3/17/15, 7:55 pm. See below.] The phrase “better living through chemistry,” derived from an old DuPont corporate slogan, has accumulated all kinds of ironic and wink-wink…

[[Click headline to continue reading.]]

Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow

March 16, 2015 – 2:16 pm

Part of the value pitching in a competition at South by Southwest is getting to speak to a room packed with potential investors and users. But winning, and the prizes that come with it, never hurts….

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More

March 13, 2015 – 7:37 am

A is for all the news up and down the West Coast this week, and much of that news was both about bio and tech. Apple launched an iPhone-based medical research platform, 23andMe has hired a former…

[[Click headline to continue reading.]]

After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug

March 12, 2015 – 4:30 am

[Updated 3/12/15 9:55 am.] Even after the FDA refused to approve the anti-cancer drug tipifarnib in 2005, some experts could see a tantalizing glimmer of potential for patients with acute myeloid…

[[Click headline to continue reading.]]

After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug

March 12, 2015 – 4:30 am

[Updated 3/12/15 9:55 am.] Even after the FDA refused to approve the anti-cancer drug tipifarnib in 2005, some experts could see a tantalizing glimmer of potential for patients with acute myeloid…

[[Click headline to continue reading.]]

At Acadia, “Mistakes Were Made,” A Drug Is Delayed & the CEO Is Out

March 11, 2015 – 4:06 pm

On Tuesday, Acadia Pharmaceuticals dropped out of two conferences and its stock price jumped, apparently because investors thought an acquisition was coming. Not quite. Instead San Diego-based Acadia…

[[Click headline to continue reading.]]

At Acadia, “Mistakes Were Made,” A Drug Is Delayed & the CEO Is Out

March 11, 2015 – 4:06 pm

On Tuesday, Acadia Pharmaceuticals dropped out of two conferences and its stock price jumped, apparently because investors thought an acquisition was coming. Not quite. Instead San Diego-based Acadia…

[[Click headline to continue reading.]]

In Move That Spells Relief, Zogenix Sells Painkiller to Pernix

March 10, 2015 – 6:50 pm

Zohydro was supposed to be a new kind of painkiller, but it gave Zogenix CEO Roger Hawley a headache that lasted more than a year. Now perhaps he can rest a little easier. After introducing Zohydro…

[[Click headline to continue reading.]]